the future of bispecific antibodies in the treatment and management of r/r follicular lymphoma
Published 1 year ago • 244 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
1:15
the role of bispecific antibodies in the treatment of r/r large b-cell lymphoma
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
5:12
the emerging potential of bispecific antibodies as monotherapy & in combination for b-cell lymphoma
-
3:12
the role of bispecific antibodies in r/r nhl: the biology of these agents and what the future holds
-
1:17
the promise of bispecific antibodies in the treatment of nhl
-
7:46
it's true, i have cancer. non-hodgkin lymphoma!
-
38:40
bispecific antibodies in lymphoma: an update
-
2:19
novel treatment options for non-hodgkin lymphoma
-
2:56
the exciting future of bispecific antibodies
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
2:03
the next generation of novel agents in development for aggressive b-cell lymphoma
-
3:49
the challenges in developing bispecific antibodies for non-hodgkin lymphoma
-
3:20
bispecific antibodies in nhl: current insights and ongoing studies
-
0:51
the role of bispecifics in wm
-
2:00
the success story of bispecific and trispecific antibodies
-
1:43
updates on the use of bispecific antibodies in mcl & the need for more studies in this space
-
1:38
using pet to predict failure to salvage therapy in patients with dlbcl
-
27:49
hodgkin disease: the past, the present, and the future
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
0:51
the future of the treatment of follicular lymphoma
-
0:45
difference between quality of life & patient-reported outcomes
-
3:01
how the treatment of dlbcl and fl are changing in the uk